John Hohneker - May 20, 2025 Form 4 Insider Report for CURIS INC (CRIS)

Role
Director
Signature
/s/ Diantha Duvall, Attorney-in-fact
Stock symbol
CRIS
Transactions as of
May 20, 2025
Transactions value $
$45,072
Form type
4
Date filed
5/22/2025, 04:13 PM
Previous filing
Jan 30, 2025
Next filing
Jun 20, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hohneker John Director 128 SPRING STREET, BUILDING C - SUITE 500, LEXINGTON /s/ Diantha Duvall, Attorney-in-fact 2025-05-22 0001695378

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRIS Non Qualified Stock Option Award $45.1K +14.4K $3.13 14.4K May 20, 2025 Common Stock 14.4K $3.13 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option grant, as disclosed in Curis Inc.'s 2025 proxy statement, was approved by the Board of Directors of Curis, Inc. on January 28, 2025, contingent upon shareholder approval of Curis's Amendment No. 1 to the Fifth Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if Amendment No. 1 to the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 20, 2025, at the 2025 annual meeting of shareholders, Curis's shareholders approved Amendment No. 1 to the Fifth Amended and Restated 2010 Plan.
F2 The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 28, 2026.